Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Capoci, Isis Regina Grenier ^a   Bonfim Mendonça, Patrícia De Souza ^a   Arita, Glaucia Sayuri ^a   Pereira, Raphaela Regina De Araújo ^a   Consolaro, Marcia Edilaine Lopes ^a   Bruschi, Marcos Luciano ^a   Negri, Melyssa ^a   Svidzinski, Terezinha Inez Estivalet ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FLUCONAZOLE; FUNGAL PROTEIN; GALLIC ACID; NYSTATIN; PHENOL; PROPOLIS;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; COLONY FORMING UNIT; CYTOTOXICITY ASSAY; DRUG ISOLATION; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VAGINA CANDIDIASIS;

EID: 84925400451     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/287693     Document Type: Article

References (49)

1. J. D. Sobel, "Vulvovaginal candidosis" The Lancet, vol. 369, no. 9577, pp. 1961-1971, 2007.
2. P. L. Fidel Jr. and J. E. Cutler, "Prospects for development of a vaccine to prevent and control vaginal candidiasis" Current Infectious Disease Reports, vol. 13, no. 1, pp. 102-107, 2011.
3. S. R. Fan and X. P. Liu, "In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis" Mycoses, vol. 54, no. 6, pp. 501-505, 2011.
4. X. P. Liu, S. R. Fan, Y. T. Peng, and H. P. Zhang, "Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012" Journal of Medical Mycology, vol. 24, no. 2, pp. 106-111, 2014.
5. D. P. Kontoyiannis, G. P. Bodey, and C. S. Mantzoros, "Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis" Mycoses, vol. 44, no. 5-6, pp. 125-135, 2001.
6. E. C. Almeida and H. Menezes, "Anti-inflammatory activity of propolis extracts: a review" Journal of Venomous Animals and Toxins, vol. 8, no. 2, pp. 191-212, 2002.
7. Y. K. Park, S. M. Alencar, and C. L. Aguiar, "Botanical origin and chemical composition of Brazilian propolis" Journal of Agricultural and Food Chemistry, vol. 50, no. 9, pp. 2502-2506, 2002.
8. G. A. Burdock, "Review of the biological properties and toxicity of bee propolis (propolis)" Food and Chemical Toxicology, vol. 36, no. 4, pp. 347-363, 1998.
9. M. Imhof, M. Lipovac, C. Kurz, J. Barta, H. C. Verhoeven, and J. C. Huber, "Propolis solution for the treatment of chronic vaginitis" International Journal of Gynecology and Obstetrics, vol. 89, no. 2, pp. 127-132, 2005.
10. R. A. Calderone andW. A. Fonzi, "Virulence factors of Candida albicans" Trends inMicrobiology, vol. 9, no. 7, pp. 327-335, 2001.
11. L. J. Douglas, "Candida biofilms and their role in infection" Trends in Microbiology, vol. 11, no. 1, pp. 30-36, 2003.
12. D. P. Camacho, M. E. L. Consolaro, E. V. Patussi, L. Donatti, A. Gasparetto, and T. I. E. Svidzinski, "Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR)" Contraception, vol. 76, no. 6, pp. 439-443, 2007.
13. M. L. Bruschi, D. S. Jones, H. Panzeri, M. P. D. Gremiao, O. de Freitas, and E. H. G. Lara, "Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, andmucoadhesive properties" Journal of Pharmaceutical Sciences, vol. 96, no. 8, pp. 2074-2089, 2007.
14. M. L. Bruschi, T. Klein, R. S. Lopes, S. L. Franco, and M. P. D. Gremiao, "Contribuicao ao protocolo de controle de qualidade da propolis e de seus extratos" Revista de Ciencias Farmaceuticas, vol. 23, no. 2, pp. 289-306, 2002.
15. Farmacopeia Brasileira vol 1-2, Agencia Nacional de Vigilancia Sanitaria, Brasilia, Brazil, 5th edition 2010.
16. R. R. A. Pereira and M. L. Bruschi, "Evaluation of two spectrophotometric methods for analysis of green propolis extract" Latin American Journal of Pharmacy, vol. 32, no. 5, pp. 719-726, 2013.
17. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, CLSI Document M27-A3, 3rd edition, 2008.
18. K. F. Dalben-Dota, M. G. I. Faria, M. L. Bruschi, S. M. Pelloso, M. E. Lopes-Consolaro, and T. I. E. Svidzinski, "Antifungal activity of propolis extract against yeasts isolated from vaginal exudates" The Journal of Alternative and Complementary Medicine, vol. 16, no. 3, pp. 285-290, 2010.
19. M. S. A. Khan and I. Ahmad, "Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans" Journal of Ethnopharmacology, vol. 140, no. 2, pp. 416-423, 2012.
20. Clinical and Laboratory Standards Institute (CLSI), "Reference method for broth dilution antifungal susceptibility testing of yeasts" Approved Standard 3rd Informational Supplement, M27-S3, CLSI, Wayne, Pa, USA, 2008.
21. G. Malich, B. Markovic, and C. Winder, "The sensitivity and specificity of theMTS tetrazoliumassay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines" Toxicology, vol. 124, no. 3, pp. 179-192, 1997.
22. J. H. Shin, S. J. Kee, M. G. Shin et al. , "Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources" Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1244-1248, 2002.
23. M. Negri, V. Goncalves, S. Silva, M. Henriques, J. Azeredo, and R. Oliveira, "Crystal violet staining to quantity Candida adhesion to epithelial cells" British Journal of Biomedical Science, vol. 67, no. 3, pp. 120-125, 2010.
24. M. Negri, S. Silva, M. Henriques, J. Azeredo, T. Svidzinski, and R. Oliveira, "Candida tropicalis biofilms: artificial urine, urinary catheters and flow model" Medical Mycology, vol. 49, no. 7, pp. 739-747, 2011.
25. J. C. P. Mello, L. A. Mentz, and P. R. Petrovick, Farmacognosia: da planta ao medicamento, EFRGS, PortoAlegreRioGrande do Sul, Brazil, 2003.
26. B. Rankovic, D. Rankovic, and D. Maric, "Antioxidant and antimicrobial activity of some lichen species" Microbiology, vol. 79, no. 6, pp. 809-815, 2010.
27. I. deOliveira, R. A. G. Lima, E. deOliveiraLima, N. M. P. Farias, and E. L. de Souza, "Atividade antifungica de oleos essenciais sobre especies de Candida" Brazilian Journal of Pharmacognosy, vol. 16, no. 2, pp. 197-201, 2006.
28. S. Sonmez, L. Kirilmaz, M. Yucesoy, B. Yucel, and B. Yilmaz, "The effect of bee propolis on oral pathogens and human gingival fibroblasts" Journal of Ethnopharmacology, vol. 102, no. 3, pp. 371-376, 2005.
29. T. P. Cushnie and A. J. Lamb, "Antimicrobial activity of flavonoids" International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343-356, 2005.
30. Farmacopeia Brasileira and Atheneu Sao Paulo, Brazil. 4th edition, 1988.
31. Y. Jin, H. K. Yip, Y. H. Samaranayake, J. Y. Yau, and L. P. Samaranayake, "Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection" Journal of Clinical Microbiology, vol. 41, no. 7, pp. 2961-2967, 2003.
32. M. M. Coogan, P. L. Fidel Jr. , M. C. Komesu, N. Maeda, and L. P. Samaranayake, "(B1) Candida and mycotic infections" Advances in Dental Research, vol. 19, no. 1, pp. 130-138, 2006.
33. A. A. Basma, Z. Zuraini, and S. Sasidharan, "A transmission electron microscopy study of the diversity of Candida albicans cells induced by Euphorbia hirta L. leaf extract in vitro" Asian Pacific Journal of Tropical Biomedicine, vol. 1, no. 1, pp. 20-22, 2011.
34. J.-D. Zhang, Z. Xu, Y.-B. Cao et al. , "Antifungal activities and action mechanisms of compounds from Tribulus terrestris L" Journal of Ethnopharmacology, vol. 103, no. 1, pp. 76-84, 2006.
35. J. A. Lee and H. Y. Chee, "In vitro antifungal activity of equol against Candida albicans" Mycobiology, vol. 38, no. 4, pp. 328-330, 2010.
36. A. Khodavandi, F. Alizadeh, F. Aala, Z. Sekawi, and P. P. Chong, "In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species" Mycopathologia, vol. 169, no. 4, pp. 287-295, 2010.
37. C. O. D. S. Frozza, C. S. C. Garcia, G. Gambato et al. , "Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis"FoodandChemical Toxicology, vol. 52, pp. 137-142, 2013.
38. G. Agarwal, G. G. Vemanaradhya, and D. S. Mehta, "Evaluation of chemical composition and efficacy of Chinese propolis extract on Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: an in vitro study" Contemporary Clinical Dentistry, vol. 3, no. 3, p. 256, 2012.
39. V. Bankova, "Chemical diversity of propolis makes it a valuable source of new biologically active compounds" Journal of ApiProduct andApiMedical Science, vol. 1, no. 2, pp. 23-28, 2009.
40. M. Barbaric, K. Miskovic, M. Bojic et al. , "Chemical composition of the ethanolic propolis extracts and its effect on HeLa cells" Journal of Ethnopharmacology, vol. 135, no. 3, pp. 772-778, 2011.
41. A. A. Berretta, P. A. De Castro, A. H. Cavalheiro et al. , "Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection" Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID641480, 18 pages, 2013.
42. R. R. A. Pereira, J. S. Ribeiro Godoy, T. I. Stivalet Svidzinski, and M. L. Bruschi, "Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis" Journal of Pharmaceutical Sciences, vol. 102, no. 4, pp. 1222-1234, 2013.
43. C. J. Diskin, T. J. Stokes, L. M. Dansby, L. Radcliff, and T. B. Carter, "Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors" Nephron Clinical Practice, vol. 107, no. 4, pp. c128-c132, 2008.
44. L. J. Douglas, "Medical importance of biofilms in Candida infections" Revista Iberoamericana de Micologia, vol. 19, no. 3, pp. 139-143, 2002.
45. A. Valentin, E. Canton, J. Peman, and G. Quindos, "In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms" Revista Iberoamericana de Micologia, vol. 24, no. 4, pp. 272-277, 2007.
46. P. A. de Castro, V. L. P. Bom, N. A. Brown et al. , "Identification of the cell targets important for propolis-induced cell death in Candida albicans" Fungal Genetics and Biology, vol. 60, pp. 74-86, 2013.
47. M. A. Al-Fattani and L. J. Douglas, "Biofilm matrix of Candida albicans and Candida tropicalis: Chemical composition and role in drug resistance" Journal of Medical Microbiology, vol. 55, no. 8, pp. 999-1008, 2006.
48. V. C. P. P. Queiroz, Avaliacao do potencial antifungico de propolis de Apis mellifera contra leveduras do genero Candida [dissertacao de mestrado] Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba, Sao Paulo, Brazil, 2010.
49. F. C. Odds, "Pathogenesis of Candida infections" Journal of the American Academy of Dermatology, vol. 31, no. 3, pp. S2-S5, 1994.